Antioxidant Potential of Momordica Charantia in Ammonium Chloride-Induced Hyperammonemic Rats by Thenmozhi, A. Justin & Subramanian, P.
Hindawi Publishing Corporation
Evidence-Based Complementaryand Alternative Medicine
Volume 2011, Article ID 612023, 7 pages
doi:10.1093/ecam/nep227
Original Article
AntioxidantPotentialofMomordicaCharantia in
AmmoniumChloride-Induced Hyperammonemic Rats
A.JustinThenmozhi andP. Subramanian
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608002,
Tamil Nadu, India
Correspondence should be addressed to P. Subramanian, psub@rediﬀmail.com
Received 26 June 2009; Accepted 1 December 2009
Copyright © 2011 A. J. Thenmozhiand P. Subramanian. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The present study was aimed to investigate the antioxidant potential of Momordica charantia fruit extract (MCE) in ammonium
chloride-induced (AC)hyperammonemicrats.Experimentalhyperammonemiawasinduced inadultmaleWistarrats(180–200g)
by intraperitoneal injections of ammonium chloride (100mgkg−1 body weight) thrice a week. The eﬀect of oral administration
(thrice a week for 8 consecutive weeks) of MCE (300mgkg−1 body weight) on blood ammonia, plasma urea, serum liver
marker enzymes and oxidative stress biomarkers in normal and experimental animals was analyzed. Hyperammonemic rats
showed a signiﬁcant increase in the activities of thiobarbituric acid reactive substances, hydroperoxides and liver markers
(alanine transaminase, aspartate transaminase and alkaline phosphatase), and the levels of glutathione peroxidase, superoxide
dismutase, catalase and reduced glutathione were decreased in the liver and brain tissues. Treatment with MCE normalized
the above-mentioned changes in hyperammonemic rats by reversing the oxidant-antioxidant imbalance during AC-induced
hyperammonemia, and oﬀered protection against hyperammonemia. Our results indicate that MCE exerting the antioxidant
potentials and maintaining the cellular integrity of the liver tissue could oﬀer protection against AC-induced hyperammonemia.
However, the exact underlying mechanism is yet to be investigated, and examination of the eﬃcacy of the active constituents of
the M. charantia on hyperammonemia is desirable.
1.Introduction
In mammals, ammonia is an important nitrogen substrate
in several reactions and plays an important role in nitrogen
homeostasis of mammalian cells. Ammonia is produced by
amino acid and protein catabolism and is toxic to brain and
muscles. Ammonia toxicity results in free-radical generation
that leads to oxidative stress and tissue damage [1]; it is
converted to urea in the liver by urea-cycle enzymes, which is
then excreted by the kidneys. Hyperammonemia may result
from genetic defect or deﬁciency of the urea-cycle enzymes
or from acquired conditions such as Reye’s syndrome, liver
failure, high-dose chemotherapy and severe infection [2].
Hyperammonemia is a major contributing factor to neu-
rological abnormalities observed in hepatic encephalopathy
and congenitaldefectsof ammonia detoxiﬁcation.Ammonia
aﬀects both excitatory and inhibitory synaptic transmission
in the mammalian brain through a variety of mechanisms
[3]. The clinical features of hyperammonemia are usually
nonspeciﬁc in adults and include vomiting, lethargy, sleep
and behavioral disturbances, hallucinations, delusions and
psychosis [4], coma and death [2].
The greatest disadvantage of the currently available
potent conventional or synthetic antihyperammonemic
agents/therapies lies in their toxicity and reappearance of
symptoms after discontinuation. Valporic acid, phenobar-
bitol and carbamazepine are some of the currently used
antiseizure and antihyperammonemic drugs. These drugs or
therapies are sometimes inadequate and can have serious
adverseeﬀects[5].Therefore,thescreeninganddevelopment
of drugs for their antihyperammonemic activity is still in
progress, and there is a growing need to ﬁnd appropriate
protective agents against hyperammonemia from traditional
medicinal plants.
Momordica charantia L (Bitter melon) is one of the most
important species belonging to the family Cucurbitaceae,
commonly known as bitter gourd or bitter melon in English.
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secondary center of diversity in China [6]. Its fruits, leaves
and roots have been shown to exhibit various biological
activities, including antidiabetic, antirheumatic, antiulcer,
anti-inﬂammatory and antitumor, and is used for treating
jaundice, leprosy and as an antivenom to snakebite [7–9].
A bitter melon fruit has a particular clinical usefulness,
similar to MAP30 (Momordica anti-HIV protein; molecular
weight: 30kDa) that is believed to have multiple functions
that could be beneﬁcial for the treatment of HIV infections
[10]. Recently,it has been found to be a powerful activator of
peroxisome proliferator-activated α-receptor that regulates
the expression of genes involved in lipid metabolism and
transport [11]. In addition, examination of the phyto-
chemicals of this plant indicated the presence of active
components like momorcharins, momordenol, momordi-
cilin, momordicins, momordicinin, momordin, momor-
dolol, charantin, charine, cryptoxanthin, cucurbitins, cucur-
bitacins, cucurbitanes, cycloartenols, diosgenin, elaeostearic
acids, erythrodiol, galacturonic acids, gentisic acid, goyagly-
cosides, goyasaponins and multiﬂorenol, which have been
isolated [12, 13]. It is a well-documented fact that most
medicinal plants are enriched with phenolic compounds
and bioﬂavonoids that have excellent antioxidant property
[14, 15].
Although various phytochemical constituents and di-
verse medicinal activities have been attributed to this plant,
nobiochemical studieshavebeen carried outtoshed lighton
theroleofM.charantia fruitextractonlivermarkerenzymes,
lipid peroxidation and antioxidant status in experimental
hyperammonemia.
2.Methods
2.1. Plant Material. The mature green M. charantia were
collected from Chidambaram, Cuddalore District, Tamil
Nadu, India. The plant was identiﬁed and authenticated
at the Herbarium of Botany Directorate in Annamalai
University. A voucher specimen (No. 1260) was deposited at
the Botany Department of Annamalai University.
2.2. Preparation of Alcoholic Extract (MCE). Alcoholic
extract of the fruit was prepared according to the method
developed by Shibib et al. [16]. One kilogram of unripe
fruit bought from the local market was thoroughly washed,
and the seeds were removed. The pulp was blended in
1500mL of 95% alcohol, and left at room temperature with
occasional shaking for 48h .The suspension was ﬁltered
through cheesecloth, and the ﬁltrate was evaporated in a
Rotovac (Buchi Labortechnik AG, Switzerland) at 40◦Ct o
remove the alcohol. The ﬁnal residue was stored at −20◦C
until further use. The residual extract was suspended in
1% (w/v) carboxymethyl cellulose (CMC), and used in the
investigation [17].
2.3. Chemicals. Ammonium chloride was purchased from
Sisco Research Laboratories, Mumbai, India. All the other
chemicals used in the study were of analytical grade.
2.4. Animals. Adult male albino Wistar rats, weighing 180–
200g bred in the Central Animal House, Rajah Muthiah
Medical College, Annamalai University, were used for the
experiment.Theanimalswerehousedinpolycarbonatecages
in a room with a 12-h day-night cycle, at a temperature of
22 ± 2◦C and humidity of 45–64%. The animals were fed
with a standard pellet diet (Hindustan Lever Ltd, Mumbai,
India) and water ad libitum. All the animal experiments were
approved by the ethical committee, Annamalai University
(Clearance No. 536/20-03-08), and were in accordance with
the guidelines of the National Institute of Nutrition (NIN),
Indian Council of Medical Research (ICMR), Hyderabad,
India. Hyperammonemia was induced in Wistar rats by
intraperitoneal injectionsofammoniumchlorideatadoseof
100mgkg−1 body weight, thrice in a week for 8 consecutive
weeks [18].
2.5. Experimental Design. In the experiment, a total of 32
rats were used. The rats were divided into four groups
of eight rats each. Group I rats received 1% (w/v) CMC
and were considered as control, Group II normal rats
were administered with MCE (300mgkg−1 body weight)
using an intragastric tube [16], Group III rats were treated
with ammonium chloride intraperitoneally (100mg kg−1
body weight) [18] and Group IV rats were treated with
ammonium chloride (100mg kg−1) + MCE (300mg kg−1).
At the end of eighth week, the rats were fasted overnight
and killed by cervical dislocation after anesthetizing with
ketamine hydrochloride (30mg kg−1 body weight; im).
Blood was collected, and plasma and serum were separated
by centrifugation. The liver and brain tissues were excised
immediately and rinsed in ice-chilled normal saline. About
500mg of the tissues were homogenized in 5.0 mL of 0.1M
Tris-HCl buﬀer (pH 7.4). The homogenate was centrifuged
and the supernatant was used for the estimation of various
biochemical parameters.
2.6. Biochemical Estimations. Blood ammonia was deter-
mined by the enzymatic kinetic colorimetric assay developed
by Wolheim [19], using an automated Roche/Hitachi 912
kit. Plasma urea was determined by the diacetyl monoxime
method [20] using automated Roche/Hitachi 912 kit. Urea
reacted with diacetyl monoxime under strong acidic con-
ditions and produced a pink-colored complex, and the
color developed was read at 540nm. Activities of aspartate
transaminase (AST) and alanine transaminase (ALT) were
assayed using the method described by Reitman and Frankel
[21], while alkaline phosphatase (ALP) was assayed by the
method described by King and Armstrong [22].
Plasma thiobarbituric acid reactive substances (TBARS)
were estimated by the method developed by Yagi [23], while
the TBARS in the liver and brain were estimated by the
method developed by Fraga et al. [24]. The estimation of
lipid hydroperoxides (HP) in plasma, liver and brain tissues
was carried out using the method described by Jiang et al.
[25],while the activity ofsuperoxide dismutase (SOD)inthe
liver and brain tissues was assayed by the method developed
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liver and brain tissues was assayed by the method described
by Sinha [27], and an estimation of reduced glutathione
(GSH) in the plasma, liver and brain tissues was made
using the method described by Ellman [28]. Furthermore,
glutathione peroxidase (GPx) activity was assayed by the
method developed by Rotruck et al. [29], and the protein in
the enzyme extract was determined by the method described
by Lowry et al. [30].
2.7. Statistical Analysis. Statistical analysis was performed
using one-way analysis of variance (ANOVA), followed by
Duncan’s multiple range test (DMRT) using SPSS software
package 13.0. The results were expressed as mean ± SD
from eight rats in each group, and P-values of <.05 were
considered as signiﬁcant.
3.Results
3.1. Antihyperammonemic and Hepatoprotective Eﬀect.
Table 1 shows the levels of blood ammonia, plasma urea
and serum AST, ALT and ALP of normal and experimental
rats. Ammonium chloride-induced (AC) rats showed
a signiﬁcantly increased level of the above-mentioned
biochemical parameters whenc o m p a r e dw i t ht h en o r m a l
rats. Oral treatment with MCE in AC rats signiﬁcantly
decreased the levels of blood ammonia, plasma urea and
serum AST, ALT and ALP, when compared with rats induced
with ammonium chloride alone.
3.2.Antilipidperoxidation Activity. Table 2showsthelevelsof
TBARS and HP in plasma and tissues (liver and brain) of the
normal and experimental rats. ACrats showed a signiﬁcantly
increased levelofTBARSand HPin plasma and tissues when
compared with the normal rats. Oral treatment with MCE in
AC rats signiﬁcantly decreased the levels of TBARS and HP
in plasma and tissues (liver and brain) when compared with
rats induced with ammonium chloride alone.
3.3. Improvement in Antioxidant Levels in MCE-Treated
Rats. The activities of SOD, CAT, GSH and GPx in the
liver and brain of the normal and experimental rats are
shown in Tables 3 and 4. AC rats exhibited signiﬁcantly
decreased activities of these antioxidant enzymes in the liver
and brain when compared with the normal CMC-treated
control rats. Furthermore, treatment with MCE in AC rats
signiﬁcantly increased these antioxidants when compared
with rats induced with ammonium chloride alone.
4.Discussion
Ammonia is present in all living organisms as a product of
degradation of proteins and other nitrogenous compounds.
At higher levels, ammonia is toxic, leading to functional
disturbances in the central nervous system that could lead to
comaanddeath.To avoidthedeleteriouseﬀectsofammonia,
ureotelic animals detoxify ammonia by incorporating it into
urea that is eliminated in urine [31, 32]. Increased levels of
circulatory ammonia and urea indicate hyperammonemic
condition in AC rats [33], which may be due to liver damage
caused by ammonia intoxication.
Numerous investigations have documented that plant
extracts containing phenolic compounds and ﬂavonoids
oﬀer ammonia detoxiﬁcation by removing excess ammonia,
urea, uric acid and creatinine during various disease con-
ditions, such as hyperammonemia, nephrotoxicity, and so
forth [34, 35]. It was reported that MCE could normalize the
levels of urea during diabetic conditions in rats [36]a n dt h e
results of our experiments corroborate these ﬁndings.
The elevated levels of circulatory liver markers and lipid
peroxidation products in AC rats might be due to the liver
damage caused by ammonia-induced free radical generation
[37]. Reports have shown that excess ammonia intoxication
leads to excessive activation of NMDA receptors leading to
neuronal degeneration and death [38, 39]. The mechanisms
by which excessive activation of NMDA receptors leads
to neuronal degeneration and death are caused by the
increased Ca2+ concentration in the postsynaptic neuron
[40, 41]. Ca2+ binds to calmodulin and activates nitric oxide
synthase (NOS), increasing the formation of nitric oxide
(NO) that contributes to the neurotoxic process. Activation
of NMDA receptors also leads to increased production of
superoxide radical, which has also been observed under in
vivoconditions [37, 42]. Superoxide and NO have the ability
to generate hydroxyl radicals [43]. This leads to oxidative
stress [1, 44], which results in increased levels of lipid
peroxidation products and decreased levels of antioxidants
in AC rats (Figure 1). Treatment with MCE in AC rats
signiﬁcantly increased the level of antioxidants with the
depletion of lipid peroxidation products, which may be due
to the inhibition of NOS and NO by MCE [45].
Under normal conditions, a dynamic equilibrium exists
between the production of reactive oxygen species (ROS)
and the antioxidant capacity of the cell [46]. Oxidative stress
occurs when ROS levels exceed the antioxidant capacity of a
cell.TheseROSarehighlytoxicandreactwithlipids,proteins
and nucleic acids, and lead to cell death via apoptosis or
necrosis [47]. Peroxidation of lipids by the action of free
radicals on unsaturated fatty acids has been implicated
in the pathogenesis of various diseases [48]. Previous
reports state that ammonium (chloride/acetate) salts induce
ammonia toxicity partly via oxidative stress, which leads
to lipid peroxidation and free-radical generation [37]. This
could be the primary cause for the central nervous system
malfunction associated with hyperammonemia. Infection,
trauma or ingestion of large amounts of proteins is usually
the precipitating factor causing hyperammonemia [49].
ROS may attack any type of molecules, but their main
target appears to be polyunsaturated fatty acids (PUFAs),
the precursors of lipid peroxide formation [50]. Free-
radicaldamagetocellularcomponentsanddecompositionof
hydroperoxide formed from oxidative breakdown of PUFAs
are important factors in the development of cellular toxicity
and pathology caused by lipid peroxidation. It is now gen-
erally accepted that lipid peroxides play an important role in
livertoxicity[51].TreatmentwithMCEinhyperammonemic
rats signiﬁcantly decreased the levels of TBARS and HP
in plasma. Earlier reports show that MCE could decrease4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀect of MCE on changes in the blood ammonia and plasma urea, serum AST, ALT and ALP of normal and experimental rats.
Groups Blood ammonia (μmol L−1)U r e a ( m g d l −1)A S T ( I U l −1)A L T ( I U l −1)A L P ( I U l −1)
Normal 89.54 ± 4.47a 10.28 ± 2.99a 72.10 ± 6.26a 24.27 ± 2.08a 74.42 ± 6.14a
Normal + MCE (300mg kg−1) 85.32 ± 8.94a 11.40 ± 0.77a 70.24 ± 6.28a 22.01 ± 1.78a 73.96 ± 4.50a
AC (100mg kg−1) 327.15 ± 26.83b 22.93 ± 1.78b 118.41 ± 10.73b 60.34 ± 5.36b 141.72 ± 12.52b
MCE (300mg kg−1) + AC 140.26 ± 17.88c 13.15 ± 0.89c 85.82 ± 8.74c 32.74 ± 2.68c 85.71 ± 7.15c
Each value is mean ± SD for 8 rats in each group. Values not sharing a common superscript (a, b and c) diﬀer signiﬁcantly at P < .05 (DMRT).
Table 2: Eﬀect of MCE on the levels of TBARS and HP in plasma, liver and brain in normaland experimental rats.
Groups Plasma TBARS
(nM ml−1)
Plasma HP
(values ×
10−5 mM dL−1)
Liver TBARS
(mM per 100 g
wet tissue)
Liver HP (mM
per 100 g wet
tissue)
Brain TBARS
(mM per 100 g
wet tissue)
Brain HP (mM
per 100 g wet
tissue)
Normal 2.74 ± 0.17a 8.40 ± 0.11a 0.86 ± 0.07a 66.08 ± 5.21a 1.06 ± 0.08a 112.00 ± 8.50a
Normal + MCE
(300mgkg−1) 2.93 ± 0.17a 8.25 ± 0.54a 0.80 ± 0.06a 64.03 ± 5.12a 0.96 ± 0.07a 111.28 ± 8.48a
AC (100mgkg−1)4 . 5 6 ± 0.35b 13.16 ± 1.01b 2.16 ± 0.14b 97.86 ± 7.03b 1.97 ± 0.15b 135.24 ± 10.30b
MCE (300mgkg−1) + AC 3.10 ± 0.17c 10.20 ± 0.89c 1.15 ± 0.11c 76.56 ± 5.81c 1.36 ± 0.11c 118.44 ± 2.76c
Each value is mean ± SD for 8 rats in each group. Values not sharing a common superscript (a, b and c) diﬀer signiﬁcantly at P < .05 (DMRT).
Activation of NMDA receptor
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Oxidative
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Figure 1: MCE attenuates the AC-induced oxidative damages.
Thick line represents inhibition.
TBARS during hypocholesterolemic conditions [52], due
to its antilipidperoxidation and free-radical scavenging
activity [53, 54], which coincides with the results of our
experiments.
Serum AST, ALT and ALP are the most sensitive markers
employed in the diagnosis of liver diseases. When the liver
cell plasma membrane is damaged, numerous enzymes
normally located in the cytosol are released into the blood
stream [55], and their estimation in serum is a useful
quantitative marker to indicate hepatocellular damage [56].
The increased activities of these serum markers observed in
our study correspond to considerable liver damage induced
in AC rats. Treatment with MCE signiﬁcantly decreased
the levels of AST, ALT and ALP, suggesting that they oﬀer
protection by preserving the structural integrity of the
hepatocellular membrane against ammonium chloride, and
our ﬁndings are in agreement with the previously published
results [36, 57].
The ROS generation in tissues is eﬃciently scavenged
by the enzymatic and nonenzymatic antioxidants. The
decrease in the activities of antioxidant enzymes is in close
relationship with the induction of lipid peroxidation [58].
Antioxidants play a major role in protecting biological
systems from reactive oxygen-derived species and reﬂect the
antioxidant capacity of the system [59]. The components of
thedefensesystem,whichhaveevolvedtoreduceandcontain
the injury from free-radical attack, include several enzymes
and a few free-radical scavenger molecules [60]. SOD plays
an important role in protecting the cells from oxidative
damage by converting superoxide radicals into hydrogen
peroxide, which is further metabolized by CAT to molecular
oxygen and water. In the present study, the decreased activity
of SOD and CAT was observed in the liver and brain tissues
ofACrats,andthisdecreasewasantagonizedwhenMCEwas
administered [61]. SOD is the ﬁrst enzyme of the scavenger
enzyme series to ameliorate the damage caused to cells by
free radicals [62], while CAT is one of the several cellular
antioxidant enzymes that provide a defense system for the
scavenging of reactive oxygen metabolites. Possibly, the MCE
used in this study might have accelerated the catabolism
of H2O2 in hyperammonemic rats due to its superoxide-
scavenging and powerful antioxidant activities [53], which
corroborate our ﬁndings.Evidence-Based Complementary and Alternative Medicine 5
Table 3: Eﬀect of MCE on the activities of SOD and CAT in the liver and brain of normal and experimental rats.
Groups Liver SOD (Ua mg−1
protein)
Liver catalase (Ub mg−1
protein)
Brain SOD (Ua mg−1
protein)
Brain catalase(Ub mg−1
protein)
Normal 9.01 ± 0.58a 84.02 ± 6.30a 7.01 ± 0.47a 3.14 ± 0.23a
Normal + MCE (300mg kg−1)9 . 7 0 ± 0.73a 85.04 ± 6.45a 7.02 ± 0.48a 3.27 ± 0.19a
AC (100mg kg−1)3 . 7 8 ± 0.29b 40.98 ± 3.11b 5.28 ± 0.30b 0.87 ± 0.07b
MCE (300mg kg−1) + AC 6.41 ± 0.38c 70.60 ± 5.37c 7.40 ± 0.35c 2.74 ± 0.21c
Each value is mean ± SD for 8 rats in each group. Values not sharing a common superscript (a, b and c) diﬀer signiﬁcantly at P < .05 (DMRT).
Ua− Ub is deﬁned as the enzyme concentration required to inhibit the OD at 560nm of chromogen production by 50% in 1min. P < .05 (DMRT).
Table 4: Eﬀect of MCE on the activities of GSH and the levels of GPx normaland experimental rats.
Groups Liver GSH (mg per 100g
wet tissue)
Liver GPx (Ud mg−1
protein)
Brain GSH (mg per
100g wet tissue)
Brain GPx (Ud mg−1
protein)
Normal 49.28 ± 3.02a 9.39 ± 0.70a 35.45 ± 2.69a 3.38 ± 0.25a
Normal + MCE (30mg kg−1) 50.46 ± 4.31a 9.85 ± 0.74a 37.40 ± 2.76a 3.57 ± 0.27a
AC (100mg kg−1) 24.86 ± 1.93b 5.06 ± 0.43b 20.94 ± 1.74b 1.19 ± 0.09b
MCE (30mg kg−1) + AC 42.79 ± 3.20c 7.57 ± 0.72c 27.62 ± 2.16c 2.69 ± 0.20c
Eachvalueismean ± SD for 8ratsin eachgroup. Valuesnot sharing a common superscript(a,b and c)diﬀer signiﬁcantlyat P < .05(DMRT). Ud:micr o gram
of GSH consumed per minute.
We observed decreased levels of GSH along with
decreased activity of GPx in the liver and brain tissues of
hyperammonemic rats. GSH is a major endogenous antioxi-
dant, which counteracts free-radical-mediated damage [63].
It forms an important substrate for GPx and several other
enzymes, which is involved in the free-radical scavenging
[64]. In the tissues, GPx is a major enzymatic component
for the disposal of peroxides, and a prolonged depression
in the activity of this enzyme may lead to the intracellular
peroxide accumulation. Decreased GSH levels might be
due to increased utilization in protecting “SH”-containing
proteins from lipid peroxides, and the unavailability of GSH
may decrease the activities of GPx in AC rats. A previous
report demonstrated that MCE could increase the level of
GSH[61]andGPx[65]indiabeticrats,which coincideswith
our results. This may be due to the increased biosynthesis of
GSH via activation of GSH synthase by MCE.
5.Conclusion
The biochemical ﬁndings of our present study indicate that
MCE exerts protection to AC-induced hyperammonemic
rats against oxidative stress. This could be due to the
prevention or inhibition of lipid peroxidative system by
its antioxidant, maintenance of cellular integrity and hep-
atoprotective eﬀect. However, the exact mechanism is still
unclear and further research on the eﬀect of the constituents
of this plant is needed.
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